300 related articles for article (PubMed ID: 17634910)
1. [Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].
Denzinger S; Hartmann A; Hofstaedter F; Knuechel R; Wild PJ; Zaak D; Stief C; Wieland WF; Stoehr R; Burger M
Urologe A; 2007 Sep; 46(9):1126-8. PubMed ID: 17634910
[No Abstract] [Full Text] [Related]
2. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
3. The photodynamic diagnosis (PDD) for early detection of carcinoma and dysplasia of the bladder.
Zumbraegel A; Bichler KH; Krause FS; Feil G; Nelde HJ
Adv Exp Med Biol; 2003; 539(Pt A):61-6. PubMed ID: 15088896
[No Abstract] [Full Text] [Related]
4. [Fluorescence cytology of the urinary bladder].
Tauber S; Liedl B; Schneede P; Liessmann F; Waidelich R; Hofstetter A
Urologe A; 2001 May; 40(3):217-21. PubMed ID: 11405131
[TBL] [Abstract][Full Text] [Related]
5. Some pitfalls in pathological staging of invasive urothelial carcinoma.
MacLennan GT; Taylor JM
J Urol; 2004 Oct; 172(4 Pt 1):1464. PubMed ID: 15371871
[No Abstract] [Full Text] [Related]
6. [Fluorescence cytology of the urinary bladder after instillation of 5-aminolevulinic acid].
Tauber S
Urologe A; 2007 Sep; 46(9):1123-5. PubMed ID: 17641864
[No Abstract] [Full Text] [Related]
7. Fluorescence cystoscopy in the diagnostics and treatment of bladder tumors.
Petrík R; Jirsa M; Dvorák E; Skoda V; Stádník B
Biomed Tech (Berl); 1998; 43 Suppl():74-5. PubMed ID: 9859264
[No Abstract] [Full Text] [Related]
8. [New information in the classification of urothelial tumors of the bladder].
Guillou L
Ann Pathol; 1999; 19(5 Suppl):S103-7. PubMed ID: 10599468
[No Abstract] [Full Text] [Related]
9. [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder].
Tschirdewahn S; Vom Dorp F
Urologe A; 2015 Apr; 54(4):480-3. PubMed ID: 25784270
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
11. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and molecular markers in urothelial carcinoma.
Agrawal R
Indian J Pathol Microbiol; 2017; 60(4):462-463. PubMed ID: 29323055
[No Abstract] [Full Text] [Related]
13. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
14. [Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder. A new means for early recognition and surveillance of urothelial cancer].
Tauber S; Brunken C; Vierbuchen M
Urologe A; 2011 Sep; 50(9):1130-3. PubMed ID: 21847682
[TBL] [Abstract][Full Text] [Related]
15. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
16. [Squamous metaplasia as a prognostic factor in urothelial carcinoma of the bladder].
Vecchioli Scaldazza C; Morosetti C
Minerva Urol Nefrol; 1992; 44(2):97-100. PubMed ID: 1411869
[TBL] [Abstract][Full Text] [Related]
17. Nested Variant Urothelial Carcinoma of the Bladder.
Shachner TR; Riedinger E; Grindstaff AD; Bienvenu J; White WM
Urology; 2020 Oct; 144():9-12. PubMed ID: 32569658
[No Abstract] [Full Text] [Related]
18. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
19. [The clinical value of fluorescence cystoscopy in the detection of superficial transitional epithelial cell carcinoma of the bladder].
Jichlinski P; Wagniéres G; Forrer M; Mizeret J; Guillou L; Schmidlin F; Graber P; Van den Bergh H; Leisinger HJ
Ann Urol (Paris); 1997; 31(1):43-8. PubMed ID: 9157821
[TBL] [Abstract][Full Text] [Related]
20. [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study].
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Rössler W
Urologe A; 2003 Oct; 42(10):1366-73. PubMed ID: 14569386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
